News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
209 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17596)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (5)
2 (305)
3 (298)
4 (217)
5 (233)
6 (147)
7 (5)
8 (2)
9 (236)
10 (272)
11 (253)
12 (267)
13 (130)
14 (5)
15 (14)
16 (219)
17 (216)
18 (216)
19 (181)
20 (159)
21 (10)
22 (15)
23 (179)
24 (237)
25 (208)
26 (209)
27 (139)
28 (19)
29 (10)
30 (258)
31 (244)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Ipsen Provides Update on Palovarotene Clinical Programs
Ipsen to reinitiate palovarotene dosing in patients 14 years of age and older with fibrodysplasia ossificans progressiva
March 26, 2020
·
11 min read
Desalting and Buffer Exchange Market to Benefit from Increased Demand from Pharmaceutical Industry
The demand within the global desalting and buffer exchange market has been rising on account of the rising popularity of chromatography experiments in the chemical industry.
March 26, 2020
·
3 min read
Personalized Retail Nutrition and Wellness Market Thrives with Growing Awareness
TMR Research discusses the future of the global personalized retail nutrition and well market in great depth.
March 26, 2020
·
2 min read
Endoscopy Equipment Market: High Demand from North America to Remain Dominant
The global endoscopy equipment market is estimated to witness notable growth in the coming years as Transparency Market Research reports.
March 26, 2020
·
4 min read
Minimally Invasive Surgery (MIS) Market: Colorectal Cancer Segment Accounted for Significant Market Share
Transparency Market Research has published a new report titled, “Minimally Invasive Surgery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.
March 26, 2020
·
5 min read
Multi-parameter Patient Monitoring Equipment Market: Constant Rise in Incidence of Chronic Diseases is one of the Key Driver
Transparency Market Research has published a new report titled, ‘Multi-parameter Patient Monitoring Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.
March 26, 2020
·
5 min read
Tumor Ablation Market: Radiofrequency Ablation of Technology Type Dominate Global Market
A fresh report published by Transparency Market Research states that the global tumor ablation market is witnessing high competition owing to increasing fragmentation.
March 26, 2020
·
4 min read
Respiratory Virus Infection Drugs Market
Viral infections disturb either the upper or the lower respiratory tract.
March 26, 2020
·
4 min read
Oncopeptides Announces 26% Overall Response Rate of Melflufen in Triple-class Refractory Multiple Myeloma Patients From the Pivotal HORIZON Study
Oncopeptides AB announces the final topline results from the pivotal phase 2 HORIZON study evaluating melflufen in relapsed refractory multiple myeloma patients.
March 26, 2020
·
5 min read
Policy
AgNovos Healthcare Receives Breakthrough Designation for Spine Device
AgNovos Healthcare announced that its newest investigational product, AGN1 Local Osteo-enhancement Procedure Small Volume Kit, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration.
March 26, 2020
·
3 min read
Previous
8 of 21
Next